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Abstract
Background: The purpose of this study is to propose the Least Absolute Shrinkage and Selection Operators
procedure (LASSO) as an alternative to conventional variable selection models, as it allows for easy interpretation
and handles multicollinearities. We developed a model on the basis of LASSO-selected parameters in order to link
associated demographical, socio-economical, clinical and immunological factors to performing tuberculosis
screening in HIV-positive patients in Ghana.
Methods: Applying the LASSO method and multivariate logistic regression analysis on a large public health data
set, we selected relevant predictors related to tuberculosis screening.
Results: One Thousand Ninety Five patients infected with HIV were enrolled into this study with 691 (63.2 %) of them
having tuberculosis screening documented in their patient folders. Predictors found to be significantly associated with
performance of tuberculosis screening can be classified into factors related to the clinician’s perception of the clinical
state, as well as those related to PLHIV’s awareness. These factors include newly diagnosed HIV infections (n = 354 (32.
42 %), aOR 1.84), current CD4+ T cell count (aOR 0.92), non-availability of HIV type (n = 787 (72.07 %), aOR 0.56), chronic
cough (n= 32 (2.93 %), aOR 5.07), intake of co-trimoxazole (n = 271 (24.82 %), aOR 2.31), vitamin supplementation (n = 220
(20.15 %), aOR 2.64) as well as the use of mosquito bed nets (n = 613 (56.14 %), aOR 1.53).
Conclusions: Accelerated TB screening among newly diagnosed HIV-patients indicates that application of the WHO
screening form for intensifying tuberculosis case finding among HIV-positive individuals in resource-limited settings is
increasingly adopted. However, screening for TB in PLHIV is still impacted by clinician’s perception of patient’s health state
and PLHIV’s health awareness. Education of staff, counselling of PLHIV and sufficient financing are needed for further
improvement in implementation of TB screening for all PLHIV. The LASSO approach proved a convenient method for
automatic variable selection in a large public health data set that requires efficient and fast algorithms.
Trials registration: ClinicalTrials.gov NCT01897909 (July 5, 2013).
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Background
Recent advances in data collection and storage tech-
niques in public health research often result in large data
sets with sometimes even more variables than observa-
tions, a phenomenon that in statistics is often termed as
the “large p and small n problem” [1]. Finding relevant
associations between variables often appears as searching
for a needle in the haystack. Usually these data do not
only include various clinical information, but also demo-
graphical and socio-economical details as well as behav-
ioural, nutritional or geographical data with many of
these variables being correlated.
Detecting relevant predictors for an outcome using
conventional explorative data analysis frameworks, such
as running univariate regression tests for each potential
preventive or risk factor and thereafter including those
parameters with p < 0.05 into a multivariate regression
model using forward or backward variable selection is
time-consuming for large data sets. In addition, it often
results in high numbers of determined predictors if col-
linearities have not been reasonably addressed [2]. Many
risk or preventive factors are also not convenient for
translating evidence into public health practice because
clinicians are usually short of time and unable to con-
sider more than a handful parameters for decision-
making during routine work [3]. They rather rely on
their individual clinical experience than on evidence-
based interrelationships if these are too complex [4].
The Least Absolute Shrinkage and Selection Operators
procedure (LASSO) offers a possible solution to these
problems. Developed in 1996 by Tibshirani, and initially
mainly used in data mining, the LASSO’s objective func-
tion penalizes the absolute size of the regression coeffi-
cients and drives the coefficients of irrelevant variables
towards zero, which results in automatic variable selec-
tion [5]. By using the advantages of subset selection and
ridge regression, the LASSO approach enables for statis-
tical modelling that is robust and allows for easy
interpretation.
We are interested in developing a predictive modelling
framework that links (at least partly correlated) demo-
graphical, socio-economical, clinical and immunological
variables to a public health outcome. Specifically, we
focus on developing a model that relates the perform-
ance of screening for co-infection with Mycobacterium
tuberculosis in patients with Human Immunodeficiency
Virus (HIV) infection to associated factors in Ghana,
West Africa. Exploring which factors are related to con-
duction and non-performance of tuberculosis (TB)
screening by health care providers is of high importance
for national and international health services, because
TB remains the most important opportunistic infection
in people living with HIV (PLHIV) and is the leading
cause of mortality and morbidity among them across
sub-Saharan Africa, including Ghana [6]. If detected, TB
is normally curable by a specific combination of antibi-
otics and by treating HIV with combination antiretro-
viral therapy (HAART) [7, 8]. In Ghana, an estimated
20,000 people developed an active TB only in 2011, of
which 22 % where not detected and the mortality rate
remains high at about 7.5 per 100,000. To address the
low case detection rate, Ghana developed a National
Tuberculosis Health Sector Strategic Plan, which in-
cludes an intensified case finding program among
PLHIV [9]. A higher detection rate of TB among PLHIV
should not only decrease the burden of co-infected HIV-
positive individuals, but also lower the rate of new TB
infections among PLHIV and protect hospital staff work-
ing at HIV outpatient departments. In order to simplify
TB screening, the World Health Organization (WHO)
has introduced a standardised screening form that con-
sists of symptom-oriented questions for resource-limited
settings. If one question is answered affirmatively, sub-
jects are considered to be “TB suspects” and further
diagnostics (sputum testing, chest X-ray) are initiated
[9]. This screening tool should help implementing TB
screening of HIV-positive patients in treatment facilities
as a standard procedure and increase the detection rate
of TB cases [10–12]. However, the rate of non-detected
cases of co-infections with TB among PLHIV in Ghana
remains high and the underlying causes are not clear to
date [9, 13]: Are PLHIV who have been on treatment for
a longer period less likely to be screened for TB because
the WHO screening form has been introduced only a
few years ago? Or do these patients have a higher chance
than more recently diagnosed patients that screening
has taken place at any of their multiple clinical visits?
Do factors, such as age, gender or religion have an im-
pact on performance of screening for TB? Are patients
with a higher education and higher income more likely
to be screened for TB than less educated patients? Is
there evidence that procedures in HIV outpatient de-
partments are still not throughout standardised and
therefore, TB screening depends on individual staff?
This paper has both, a methodological and an empir-
ical objective. The methodological aim is to propose the
LASSO method as a convenient tool for explorative data
analysis, variable selection and model interpretation in
complex public health data sets. To accomplish this ob-
jective, we investigated the factors associated with per-
formance of TB screening of HIV-positive patients on
basis of a large data set that was obtained at a Ghanaian
HIV treatment facility. The next section deals with the
theoretical mathematical framework of the LASSO and
illustrates its practical implementation within a statistical
framework using real data from the clinic in Kumasi,
Ghana. The result section summarizes the cohort char-
acteristics as well as the empirical findings. We conclude
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by discussing the study results and their implication as
well as the methodological role and limitations of the
LASSO procedure in public health data sets.
Methods
Data set
Between November 2011 and November 2012, adult HIV-
positive patients consecutively presenting to the HIV
outpatient department at the Komfo Anokye Teaching
Hospital in Kumasi, Ghana, were enrolled into this study
after written informed consent was obtained. The cohort
comprised newly diagnosed, as well as HIV-positive pa-
tients already in care. The latter encompassed therapy-
naïve individuals and patients on HAART. The present
work was part of the HHECO study (NCT01897909) and
approved by the appropriate ethics committees in Ghana
and Germany. Demographical, socio-economical and clin-
ical data were collected using a standardized questionnaire.
Medical history and routine laboratory parameters were re-
corded from patient’s folders. Blood samples were obtained
for analysis of CD4+/CD8+ T cell counts. As this study was
conducted at a hospital within a so called “real life setting”,
missing values in the data set occurred due to national
stock outs of reagents needed for laboratory tests, patients
forgetting to bring their test results, or other reasons. The
cohort included a wide spectrum of HIV-infected patients
regarding duration of HIV diagnosis and current status of
antiretroviral therapy.
Statistical method – the LASSO
The LASSO procedure is a shrinkage method within linear
regression models that enables to shrink estimates of irrele-
vant variables towards zero and thus, allows for automatic
variable selection. The LASSO combines the advantages of
subset selection procedure (ease of interpretation) and
ridge regression (robustness). In contrast to ordinary least
squares (OLS), where estimates are obtained by minimizing
the residual square error and therefore, tend to be overesti-
mated although they are best linear unbiased estimators
(1), penalized regression models minimize the regression
coefficient by introduction of an auxiliary condition [14].
β^OLS ¼ argminβ y−Xβj j2
  ð1Þ
In LASSO the auxiliary condition for β allows for pen-
alizing the absolute size of the regression coefficient on
basis of the tuning parameter value λ (2).








The solution requires the LASSO estimates themselves
shrinking towards zero. As a result, automatic variable
selection is performed since only non-zero estimates
have influence on the target variable. λ is a user-defined
parameter that controls the amount of shrinkage, with
increasing values of λ resulting in larger shrinkage. To
choose the appropriate value of λ, cross-validation is the
simplest and most widely used method [14–16].
Concerning the LASSO estimates, due to shrinkage
the non-zero coefficients are generally biased towards
zero. To reduce this bias, a common approach is to run
the LASSO in a first step in order to identify the set of
non-zero estimators and in a second step to fit an unre-
stricted model to the selected predictors. Alternatively,
the LASSO can be applied in the second step again, but
then using only the selected variables from the first step.
Then, due to fewer variables and hence, less noise in the
second run, λ is chosen with a smaller value. As a conse-
quence, estimators will be shrunken less than in the first
run of LASSO [15].
The LASSO is especially helpful in large data sets where
efficient and fast algorithms are essential. Regarding the
presence of multicollinearity among predictors, LASSO es-
timators are more stable and produce sparser solutions
than those in OLS, where multicollinearity would lead to
poor parameter estimates and hence to wrong inferences.
However, since the LASSO penalty expects only a small set
of coefficients to be non-zero or not close to zero, the
method is not robust to high correlations among predictors
as it will then quite arbitrarily choose one and drop the
others. In this case, application of other variable selection
procedures, such as elastic net, might be more suitable [17].
Data analysis
Concerning the outcome variable, which states whether
the TB screening has been done or not, a default in TB
screening was defined if either a screening for TB has not
been done or if an asserted screening was not documented
in the patient’s folder. Among the outcome variable and
predictors, high numbers of missing values occurred if
some costly laboratory tests were not covered by the na-
tional AIDS programme and patients were not able to pay
for these tests. Categorical variables with more than two
categories were coded into dummy variables, whereby cat-
egories with the largest number of observations were de-
fined as base category. For the missing values, the dummy
coding method [18] was used for two reasons: First, delet-
ing not fully observed cases or imputing missing values is
impractical due to a high number of missing values. Sec-
ond, many variables refer to laboratory test results and a
missing value mostly indicates that the corresponding
blood test has not been done for some reason. Therefore,
missing values themselves carry important information as
the outcome variable tells whether the TB screening has
been done or not. The dummy coding method works as
follows: For categorical variables, an extra category is built
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for missing values. For numeric variables, an extra dummy
variable is created where 0 indicates an observed variable,
whereas 1 indicates a missing observation. Subsequently,
missing values in the numeric variable can be replaced by
a constant value, e.g. 0. To address the high number of
new HIV diagnoses coming to the clinic for the first time,
we coded an extra dummy for this case.
In order to identify relevant predictors, all explanatory
variables available in the data set were entered into the
LASSO procedure. The optimal penalty parameter λ was
determined by 10-fold cross-validation. In a second step,
shrinkage bias in selected non-zero coefficients was re-
duced by fitting logistic regression to the preselected
predictors. The pseudo R-squared resulting from the lo-
gistic regression is not a reliable measure for the model
validity because it ignores the variable selection step. In
order to calculate a reliable measure for the model valid-
ity here, we used the conventional validation technique
and therefore, randomly split the data into two data sets.
The first data set contained 70 % of the data and was
used as training data on which variable selection via the
LASSO was done. The remaining 30 % were used as the
test data on which the logistic regression and the corre-
sponding pseudo R-squared were calculated. To reduce
the random effect arising out of the random split of the
data, this procedure was repeated 10 times and the aver-
age value of the obtained pseudo R-squareds was calcu-
lated. This procedure was only done for the calculation
of the pseudo R-squared, all other results were obtained
by applying LASSO and logistic regression on the whole
data set. For summary of our model construction steps,
see Fig. 1. Analyses were done by using Stata (version
10.1) and R software for statistical computing (version
3.1.2) using the glmnet package [19].
Results
Cohort characteristics
One Thousand Ninety Five HIV-positive patients were en-
rolled into this study. Three patients were excluded from
the data analysis because information on the outcome
variable was not available in the study data. At the time of
recruitment, 690 participants (63.19 %) had performance
of TB screening documented in their folder.
Participants without TB screening were diagnosed
with HIV for a longer time period compared to those
with documentation (mean 3.05 vs. 2.04 years, p <
0.001). They were more likely to be on antiretroviral
therapy (n = 239 (59.45 %) vs. n = 291 (42.17 %), p <
0.001) and reported less often to use a mosquito bed
net (n = 192 (47.88 %) vs. n = 421 (61.10 %), p < 0.001)
compared to those for whom a TB screening was done
and documented. The sub-groups did not differ in
terms of age, gender, religion, education, occupation
and socio-economic status (Table 1).
Factors associated with performance of tuberculosis
screening
As a result of coding dummies, the number of vari-
ables entering into the LASSO procedure increased
from initially 101 to 156 variables. All parameters pre-
selected via the LASSO, were included into the logistic
multivariate regression model. Results show that un-
availability of a test result for the HIV type (n = 305
(27.39 %), aOR 0.56, 95 % CI 0.41–0.77, p < 0.001), no
information on the symptom of acute fever (n = 407
(37.27 %), aOR 0.511, 95 % CI 0.37–0.71, p <0.001),
high haemoglobin (aOR 0.97, 95 % CI 0.95–1.0, p =
0.041) and a high CD4+ T cell count (aOR 0.92, 95 %
CI 0.88–0.97, p < 0.001) are negatively associated with
the performance of TB screening (Table 2).
A positive association between predictors and the
screening for TB could be observed for newly diagnosed
HIV infections (n = 354 (32.42 %) aOR 1.84, 95 % CI
1.24–2.75, p = 0.003), chronic cough during the past six
months (n = 32 (2.93 %), aOR 5.07, 95 % CI 1.62–22.68,
p = 0.013), the intake of co-trimoxazole (n = 271 (24.82),
aOR 2.31, 95 % CI 1.52–3.54, p < 0.001) or vitamin sup-
plementation (n = 220 (20.15 %), aOR 2.64, 95 % CI
1.72–4.10, p < 0.001), as well as for the use of a mosquito
bed net (n = 613 (56.14 %), aOR 1.53, 95 % CI 1.15–2.05,
p = 0.004).
Although preselected by LASSO to be associated with
conduction of TB screening, the parameters “Combin-
ation therapy with Lamivudine” and “intake of regular





LASSO: for each dummy variable determine
optimal by k-fold cross-validation
Final model on basis of
LASSO-selected predictors
Model validation
Fig. 1 legend: m = number of variable categories; mv =missing
values. Summary of the model construction steps
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medicine” were not found to be significant predictors at
the 5 % level in the final regression model. Finally, the
measure of model validity pseudo R-squared was deter-
mined with a value of 0.24.
Discussion
Screening HIV-positive patients for TB is essential for
increasing the TB case detection rate and lowering the
burden in PLHIV. Undetected cases of active TB are
not only a common cause of death in HIV-positive in-
dividuals, but also a high risk for family members,
hospital staff and fuel the expansion of multi resistant
TB strains [20, 21]. To address shortages of staff and
time, the WHO developed a TB screening form that
simplifies integration of TB screening as a standard
procedure in the clinical routine in resource-limited
settings. With the help of the Global Fund to fight
AIDS, Tuberculosis and Malaria, Ghana has put much
effort into restructuring and integrating TB and HIV
services within the public health system during the
last years [22]. However, our data analysis indicates
that there still is a high proportion of HIV-positive pa-
tients in Ghana, for whom TB screening has not been
done or documented (36.81 %). These findings are in
line with results from a survey conducted by the TB
Control Programme in Ghana in 2013, in which the
TB prevalence appears to be higher than the one esti-
mated by the WHO [23]. This questions the estimated








n = 690 (63.19 %) n = 402 (36.81 %)
Gender, n (%) 0.070
Female 516 (74.78) 320 (79.60)
Male 174 (25.22) 82 (20.40)
Age in years,
mean (± SD)




Yes 291 (42.17) 239 (59.45)




2.04 (2.72) 3.05 (2.73) <0.001
Religion, n (%) 0.751
Christian 590 (85.51) 345 (85.82)
Moslem 87 (12.61) 50 (12.44)
Traditional
African religion
2 (0.18) 0 (0)






130 (18.84) 82 (20.4)
Primary
education
97 (14.06) 82 (20.4)
Junior High
School
321 (46.52) 168 (41.79)
Senior High
School
103 (14.93) 52 (12.94)
Tertiary
education




Housewife 14 (2.03) 4 (1.0)
Farmer 58 (8.41) 30 (7.46)
Trader 347 (50.29) 225 (55.97)
Salary
worker
44 (6.38) 21 (5.22)
Others 141 (20.43) 75 (18.66)
Currently
unemployed




Yes 366 (53.04) 219 (54.48)





Table 1 Cohort characteristics (Continued)
Yes 639 (92.61) 375 (93.28)





Yes 562 (81.45) 329 (81.84)




Yes 491 (71.16) 278 (69.15)




Yes 54 (7.83) 45 (11.19)





Yes 421 (61.01) 192 (47.76)
No 268 (38.84) 209 (51.99)
HAART highly active antiretroviral therapy, TB Tuberculosis, Without TB
screening Screening not done/not documented, p was determined by chi-
square test or two-group mean-comparison t-test as appropriate
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case detection rate of 88 %, that is likely to be overes-
timated [24]. Recent literature divides the underlying
reasons for delay in TB diagnostics and treatment gen-
erally into health provider associated or patient associ-
ated factors [25]. The objective of this study was to
identify factors related to performing of TB screening,
which could serve as a contribution that enables pub-
lic health decision makers to close these gaps and to
increase the TB case detection rate among PLHIV.
According to our analysis, the odds of conduction and
documentation of TB screening were much higher with
newly diagnosed HIV infection (aOR 1.84) compared to
those who were not newly diagnosed. This suggests that
the WHO screening tool has been adopted as a standard
procedure for new HIV cases like in many other sub-
Saharan countries [26, 27]. But in order to reach fully
successful implementation, screening of all cases has to
be targeted [28].
Results also show that a high CD4+ T cell count and
high haemoglobin, which indicate a good control of the
HIV-infection, are negatively associated with TB screen-
ing, whereas chronic coughing during the past six
months, which is a possible sign of active TB, is posi-
tively associated but does not trigger TB screening in
every case. These findings demonstrate that TB screen-
ing is still related to current health status as it was prac-
tice before the WHO recommended TB screening as
standard procedure regardless of the patient’s disease
progress. A similar observation has been made in South
Africa, where the burden of HIV/TB co-infection is high
Table 2 Factors associated with conduction of TB-screening – aOR from logistic regression
Dummy-variable chosen by LASSO Number enrolledn [%] Odds ratio 95 % CI P-value
Time since HIV diagnosis (years) 0.003
> 0 (and not available) 703 [64.65] (32 [2.93]) 1
0 354 [32.42] 1.844 1.237–2.753
HIV Type <0.001
available 787 [72.07] 1
not available 305 [27.93] 0.562 0.409–0.771
CD4+ T cell count/(μl*100) 504 [46.15] 0.924 0.882–0.966 <0.001
Haemoglobin in g/dL 512 [46.89] 0.9734 0.949–0.999 0.041
Combination therapy with Lamivudine 0.858
yes 516 [47.25] 0.967 0.668–1.399
no 576 [52.75] 1
Information on acute fever <0.001
available 685 [62.73] 1 0.369–0.707
not available 407 [37.27] 0.511
Chronic cough (past Six months) 0.013
yes 32 [2.93] 5.065 1.622–22.677
no (and not available) 1,059 [96.98] (1 [0.09]) 1
Intake of regular medicine 0.661
yes 362 (33.15) 1.089 0.743–1.596
no (and not available) 728 [66.67] (2 [0.18]) 1
Intake of co-trimoxazole
yes 271 [24.82] 2.311 1.523–3.536 <0.001
no 821 [75.18] 1
Supplementation with vitamins <0.001
yes 220 [20.15] 2.641 1.722–4.101
no 872 [79.85] 1
Use of mosquito bed net 0.004
yes 613 [56.14] 1.535 1.149–2.0515
no (and not available) 477 [43.68] (2 [0.18]) 1
Total number of observations = 1,092; TB Tuberculosis, Pseudo R-squared = 0.24
Mueller-Using et al. BMC Public Health  (2016) 16:563 Page 6 of 8
and the WHO stage was associated with delay in TB
diagnosis and treatment [29]. Although it is advisable to
screen patients with more advanced HIV stages more
often, it should not replace general TB screening of
every HIV case [30].
Evidence was found for a positive association between
TB screening and usage of mosquito bed nets. This associ-
ation did not appear for any other socio-economic param-
eter such as age, gender, religion, or educational level, so
that usage of bed nets can rather be seen as a sign of pa-
tient’s health awareness. This finding is in accordance with
another study conducted in Ghana in 2013 where
Osei et al. found an independent inverse relationship be-
tween holding a health insurance and patient-associated
delay in TB diagnostics, even though TB diagnostics and
treatment are provided free of charge [31]. Also positively
associated are preventive measures, such as vitamin sup-
plementation and prescription of co-trimoxazole, as indica-
tors for comprehensive medical care provided by clinical
staff. However, missing information on current symptoms
like acute fever or the unavailability of HIV type test results
are negatively associated with screening for TB, which sug-
gests that defaults in various preventive measures often go
hand in hand. Several other studies have claimed that low
quality or lack of records are not only harmful for individ-
ual patients because clinical or laboratory tests have to be
repeated or are skipped. They state that missing data are
likely to result in overestimation of case finding rates and
therefore could lead to suboptimal decision-making in the
public health sector [32–34].
Conclusions
In order to address the LASSO’s limitation of selected esti-
mates being shrunken and therefore biased we used the
LASSO-method only for preselection of predictors. Thus,
fitting an unrestricted linear model to LASSO-preselected
predictors remains essential for further data analysis. An-
other limitation of this study is that data on patients’ and
clinicians’ knowledge about TB screening was not collected.
However, since this knowledge is likely to show a link to
whether screening is conducted or not, further research on
this topic should include additional behavioural factors.
Based on the results of this study the following conclu-
sions can be offered:
– Patients should be counselled on individual and
social benefits of preventive measures.
– Education and external monitoring of HIV clinic
staff and the integration of TB screening into
standard operation procedures is essential as
screening activities are decisive for increased case
finding.
– Sufficient financing of health systems has to be
provided to avoid under-staffing in integrated
services and stock outs of drugs and reagents as a
potential reason for decreasing staff and patient mo-
tivation [35–37].
– Applying the LASSO method to our large public
health data set was of crucial importance for
identifying relevant predictor variables that were
related to our outcome variable. Because the LASSO
offers solutions to problems that are not addressed
within conventional variable selection models, it
proved as a valuable and efficient procedure for our
analysis.
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